PT  - JOURNAL ARTICLE
AU  - Pandya, N A
AU  - Atra, A A
AU  - Riley, U
AU  - Pinkerton, C R
TI  - Role of itraconazole in haematology/oncology
AID  - 10.1136/adc.88.3.258
DP  - 2003 Mar 01
TA  - Archives of Disease in Childhood
PG  - 258--260
VI  - 88
IP  - 3
4099  - http://adc.bmj.com/content/88/3/258.short
4100  - http://adc.bmj.com/content/88/3/258.full
SO  - Arch Dis Child2003 Mar 01; 88
AB  - The antifungal agents most frequently used in prophylaxis and treatment are amphotericin B (and its new lipid forms) and azoles such as fluconazole, itraconazole, and more recently voriconazole. This review assesses the role of itraconazole in paediatric haematology/oncology practice. Its broader spectrum of activity and availability in oral and intravenous forms allow a flexible approach in the management of fungal infections.